Employees of Korea Janssen held an event on May 19 to commemorate World Inflammatory Bowel Disease Day and shared encouraging messages that patients with inflammatory bowel disease can return to their daily lives.

Employees of Korea Janssen held an event on May 19 to commemorate World Inflammatory Bowel Disease Day and shared encouraging messages that patients with inflammatory bowel disease can return to their daily lives.

View original image


[Asia Economy Reporter Lee Gwan-joo] Janssen Korea launched the 'With IBD' campaign on the 19th to support patients with inflammatory bowel disease (IBD) in observance of 'World IBD Day.'


Inflammatory bowel disease (IBD) is a condition characterized by chronic inflammation of the digestive tract. During active phases when inflammation worsens, patients often experience frequent diarrhea, abdominal pain, fatigue, and weight loss, causing significant difficulties in daily life.


The cause and cure of the disease are still unknown, and since it is a chronic condition with alternating remission periods without symptoms and active phases with symptoms, long-term management is necessary. In severe cases, complications such as intestinal strictures and perforations may require surgery; however, with the advent of new treatments and improvements in medical environments, patients can now expect to maintain remission and lead normal daily lives.


Janssen Korea planned this campaign to emphasize that patients with inflammatory bowel disease can also enjoy ordinary daily lives. Employees participating in the campaign delivered messages of hope for patients' return to daily life and reaffirmed their commitment to continuously improving the paradigm of IBD treatment and management to enhance the quality of life for patients, reflecting their long-standing contributions to the field of IBD treatment.



Chae-ri Chan, CEO of Janssen Korea, said, “We are proud to participate in activities to raise awareness of inflammatory bowel disease and support patients. Beyond providing appropriate treatment options and developing new therapies, we will also dedicate ourselves to helping society understand patients through disease education programs.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing